Shumei Kato, MD, discusses the characterization of BRAF mutations in oncology.
Shumei Kato, MD
Advertisement
Articles by Shumei Kato, MD
Advertisement
Latest Updated Articles
Dr. Kato on the Characterization of BRAF Mutations in OncologyPublished: January 31st 2022 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5